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Summary.-Since the tumour-selective cytotoxic activity of activated macrophages
in vitro can be attributed to depletion of the culture medium of L-arginine by macro-
phage arginase, a series of experiments was designed to determine whether such a
mechanism could operate in vivo.
Extracellular fluid obtained from Gullino chambers within established tumours
contained high levels of arginase, no detectable arginine and high levels of ornithine.
When tumours were disaggregated into single-cell suspensions, arginase was
readily detected within tumour macrophages but not within malignant cells. Inflam-
matory ascites induced in mice by Corynebacterium parvum was rich in arginase, de-
pleted of L-arginine and cytotoxic in vitro to L5178Y and V79 cells. High levels of
arginase in the ascites fluid were associated with resistance to challenge with syn-
geneic L5178Y cells.
Lymph collected from the cisterna chyli in rats bearing a macrophage-rich sar-
coma on the small bowel contained elevated levels of arginase, was depleted of
arginine and contained increased concentrations of ornithine.
We conclude that in sites of macrophage infiltration there is microenvironmental
arginine depletion due to the action of arginase, and that arginase release could
represent an important macrophage effector mechanism against a variety of targets,
including malignant cells, virus-infected cells, fungi and parasites.
WHEN "activated" by a variety of
stimuli, macrophages synthesize and re-
lease a bewildering array of biologically
active macromolecules. One such product,
arginase, is ofinterest to us since, as Kung
et al. (1977) have shown, induction of this
enzyme in vitro may suppress T-cell
function by depleting L-arginine from the
culture medium. Furthermore, the selec-
tive in vitro cytotoxic activity of zymosan
or lipopolysaccharide (LPS)-activated
rodent macrophages for cultured malig-
nant cells may be due to lethal deprivation
of L-arginine mediated by arginase
(Currie, 1978; Currie & Basham, 1978).
Since L-arginine, not an essential amino
acid for normal adult animals, is present
in relatively high concentrations through-
out the extracellular fluid, arginase-
mediated arginine deprivation of target
cells (malignant cells, micro-organisms,
virus-infected cells or parasites) can only
be envisaged, if at all, as a microenviron-
mental phenomenon occurring at or near
the surface ofthe macrophage (by analogy,
say, with neuromuscular transmission) or
in the centre of chronic inflammatory
lesions such as granulomas, macrophage-
rich tumours or inflammatory exudates.
This communication describes a series
of experiments designed to determine
whether microenvironmental arginine de-
pletion occurs in tumours and inflam-
matory sites. The results indicate that, in
the sites of macrophage infiltration ex-
amined, there is a profound fall in the
concentration of L-arginine in the extra-
cellular fluid associated with high levels of
arginase activity, and that such micro-
environmental depletion could play anG. A. CURRIE, L. GYURE AND L. CIFUENTES
important role in vivo as an effector func-
tion ofmacrophages.
MATERIALS AND METHODS
Enzyme assays.-Arginase was estimated
using the method of Schimke (1964) after
Mn++ activation, and the results were ex-
pressed as pM urea/min/ml. Lysozyme was
estimated by the lysoplate method employing
appropriate species standards (Osserman &
Lawlor, 1966) and the results expressed in
[kg/ml. Amino acid estimations were kindly
performed by Dr John Walker using a J180
(Rank-Hilger) ion-exchange chromatograph.
Tumours.-A variety of rat and mouse
tumours were used. The following tumours
are syngeneic in inbred Hooded rats: HSN-
TC, a benzpyrene-induced well-differentiated
fibrosarcoma, is highly immunogenic and
slow-growing and it rarely metastasizes. It
was derived as a tissue-culture subline of the
HSN sarcoma. The parent HSN tumour is
less immunogenic and grows more rapidly in
vivo.
MC28, a feebly immunogenic methyl-
cholanthrene-induced anaplastic sarcoma
which spontaneously metastasizes.
MC26, an immunogenic methylcholan-
threne-induced fibrosarcoma which rarely
metastasizes.
The mouse tumours used were: L5178YE,
an immunogenic methylcholanthrene-induced
thymic lymphoma syngeneic in DBA2 mice,
and FS6 and FS29, both of which are im-
munogenic methylcholanthrene-induced sar-
comas syngeneic in C57BL/Cbi mice.
Macrophage content.-As a rough guide to
the macrophage content of the various
tumours studied, the method of Evans (1972)
was used. This method relies on adherence to
glass of macrophages in the presence of
trypsin.
Gullino chambers.-Micropore chambers,
similar to those described by Gullino et al.
(1964), were constructed with 2mm-thick
16mm (inside diameter) perspex rings, into
which pp90 (Portex) tubes were inserted.
Both sides of each ring were covered with
nylon-reinforced Millipore filters (WHP
02500) with a pore size of 0-45 ,um.
Tumour fragments were dissected under
sterile conditions and mechanically chopped
with scissors. The chambers were lightly
coated on both sides with the resulting
tumour "pulp" and inserted s.c. into ether-
anaesthetized rats. The chambers were intro-
duced via a transverse incision in the dorsal
thoracic region and were gently eased to lie
in the dorsal caudal region. The drainage tube
was inserted into a subcutaneous channel
(with the tip heat-sealed) and the wound
closed over it.
The animals were given antibiotic cover by
daily i.p. injections of 20,000 u of benzyl
penicillin and 20 mg of streptomycin sus-
pended in 2 ml saline. Similar chambers were
also inserted without tumour tissue into
normal rats to provide a source of "normal"
s.c. tissue fluid. Extracellular fluid samples
were obtained when the tumours had reached
a diameter of about 3-4 cm (15-20 days).
Control normal fluids were obtained at the
same time after chamber insertion. The
drainage tube was exteriorized by reopening
the original incision, the tip cut off and the
fluid collected with the animals in Bollman
restraining cages. Histopathological examina-
tion ofthe chambers within growing tumours
or lying s.c. in normal animals revealed
minimal host inflammatory reactions. Fur-
thermore, the membrane surfaces ofchambers
within growing tumours were completely
covered by, and in intimate contact with,
living tumour tissue, without evidence of
necrosis, fibrosis, fibrin deposition or cyst
formation. Lysozyme content of the fluids
obtained from s.c. chambers in normal rats
was used as a check for local inflammation
due to low-grade infection or reactions to the
chamber materials. Elevated lysozyme levels
in fluids from control chambers were fre-
quently detected in the early stages of this
study, but were less frequent in animals re-
ceiving antibiotic cover.
Inflammatory ascites.-Multiple i.p. injec-
tions of Corynebacterium parvum (Coparvax,
Wellcome) into mice promote the develop-
ment of a macrophage-rich inflammatory
ascites. DBA2 female mice were injected i.p.
with 350 ,ug C. parvum in saline. Seven days
later they received an additional i.p. dose of
100 jug C. parvum. The resulting cellular
ascites was collected on Days 1 to 8 after the
last injection. The fluid was collected into ice-
cold tubes, centrifuged in the cold and then
ultra-filtered at 40C using CT50 (Amicon)
cones. The ultra-filtrate was examined for
ornithine and arginine content and the
fraction >50 kd was examined for arginase
activity. Ascitic-fluid samples and the cells
obtained from these were also examined for
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cytotoxic activity. The details of the assays
are described below.
Colony inhibition of V79 cells.-V79
Chinese hamster lung cells obtained from
stock cultures by trypinization were sus-
pended in RPM1-1640 medium plus 10%
heat-inactivated foetal bovine serum at 100
cells/ml. The cells were added in lml volumes
to the wells of Linbro 24-well disposable
plastic culture plates and were allowed to
adhere for 2 h at 37°C in 5% CO2 in humid air.
After- the addition of the test materials in
fresh medium (and controls) the plates were
incubated for a further 4 days. The plates
were then rinsed in PBS, fixed in methanol
and stained with crystal violet (1: 2000). The
number of discrete colonies in each well was
counted under low-power microscopy (with
a stage graticule). The results were expressed
as % colony survival. Each observation was
made in triplicate.
Growth inhibition of L5178YE cells.-Cells
of this DBA2 lymphoma were obtained from
mice bearing ascitic tumour, washed, sus-
pended in RPM1 1640 plus 10% heat-
inactivated calf serum, and added at 8 x 104/
ml in Iml volumes into disposable Linbro
culture trays. After the addition of test
materials (and controls) the cultures were
incubated for 24 h at 37°C in 5% CO2 in
humid air. The cellular content of each well
was then counted, after careful resuspension,
in a haemocytometer. The results (obtained
from triplicate wells) were expressed as per
cent growth. Control cultures underwent
about 2 doublings and represented the 100%
growth. Cell counts less than the inoculum
(i.e. cytolysis) were expressed as -ve growth.
Tumour macrophages.-Tumours growing
s.c. in syngeneic rats or mice were removed
aseptically, disaggregated with 0.1% trypsin
blue plus 0.1% collagenase, and the resulting
cell suspensions plated into 25cm2 disposable
plastic culture flasks. After incubation at
37°C for 1 h the flasks were well washed and
then exposed to 0-1% trypsin for 5 min. The
tumour cells removed were transferred to
another flask in fresh medium and allowed to
adhere. More than 95% of the trypsin-
resistant cells were macrophages, as judged
by morphological criteria, presence of Fc
receptors, phagocytosis and the production
of lysozyme. The malignant cell cultures
obtained by trypsin subculture contained less
than 1% macrophages as defined by these
criteria. Duplicate flasks were rinsed and
treated with 6% citric acid plus 1: 2000
crystal violet for 30 min and the nuclei
counted as a guide to the cell content of each
flask.
Flasks of tumour cells or tumour macro-
phages were washed with PBS and then
exposed to 2 ml distilled water at 4°C for
15 min. The flasks were freeze-thawed twice,
the lysate centrifuged and passed through an
0-22ym millipore filter and then assayed for
arginase content. Normal peritoneal-exudate
macrophages from C57/BL/Cbi female mice
were treated in the same way (i.e. tryp-
sinized, plated, retrypsinized) and their
arginase content examined. Arginase activity
was expressed as ,umol urea/min/106 cells.
Tumour lynmph.-HSNTC tumour was in-
oculated via laparotomy into Peyer's patches
in anaesthetized syngeneic hooded rats and
was allowed to grow for 3-4 weeks. Under
general anaesthesia a fine cannula was then
inserted into the cisterna chyli and exterior-
ized. The wounds were resutured and the
animals allowed to recover in Bollman re-
straining cages with free access to food and
water. Samples of cisterna chyli lymph were
obtained at various times after operation.
Control lymph samples were obtained from
similarly treated normal rats. Samples of
HSNTC tumour growing on the bowel were
examined by the method ofEvans (1972) and
were found to contain 32-42% macrophages.
In some experiments the animals had pre-
viously had their mesenteric lymph nodes
excised. Lymphatic drainage of the Peyer's
patches was re-established within 3 weeks
before inoculation of the tumour.
RESULTS
Gullino chambers
The data are shown in Table I. Extra-
cellular fluid obtained from chambers
implanted s.c. in normal rats contained no
detectable arginase, and levels oflysozyme
similar to those ofnormal serum. Further-
more, the levels of arginine and ornithine
also resembled those of normal serum.
Fluids drained from chambers within
the MC26, MC28 and HSN sarcomas, how-
ever, contained high concentrations of
both lysozyme and arginase. Elevated
levels of ornithine were found, and a total
absence of detectable free L-arginine.
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TABLE I. Aryinase levels in interstitial
fluid from Gullino chambers within rat
sarcomas and normal subcutaneous
tissues (NST)
NST
HSN
MC26
MC28
Lyso-
zyme
Kg/ml
9-2
38-0
48-1
32-0
Arginase
,umol
urea/
min/ml
0
1*8
1-85
0-65
Argi-
nine
nmol/ml
179*
0
0
trace
Orni-
thine
nmol/ml
158*
396
405
327
* The levels ofarginine and ornithine in the cham-
ber fluid from normal s.c. tissues were similar to
serum levels in the same rats indicating good
equilibration. In the tumour-bearing rats the serum
levels ofthese amino acids were similar to the normal
levels.
Histopathologically there was little evi-
dence of polymorphonuclear leucocyte in-
filtration of the chamber-containing
tumours, and it is concluded that the
lysozyme and arginase are probably de-
rived from the large number of macro-
phages resident within the tumour mass.
We have been unable to detect arginase in
lysates of polymorphonuclear leucocytes.
Tumour macrophages
Results are shown in Table II. Arginase
was readily detectable inlysatesoftumour-
derived macrophages but was undetect-
able in lysates ofmacrophage-free tumour
cells. Furthermore, supernatant media
from 24h cultures of such tumour macro-
phages also contained arginase activity,
whereas supernantants from the appro-
priate malignant cell cultures did not.
Normal peritoneal-exudate macrophages,
however, when treated in a similarfashion,
contained no detectable arginase activity,
an observation which suggests that the
tumour macrophages are in an activated
state.
Inflammatory ascites
Ascites fluid induced by thei.p. injection
of C. parvum contained very high levels of
arginase activity (see Table III). Ultra-
TABLE II.-Arginase content oftumour celtls
and tumour macrophages (,umol urea/
min/106 cells)
Normal CBA
Endotoxin
treated CBA
HSN-TC
MC26
FS6
FS28
Tumour Macro-
cells phages
<0-005
0-19
0 034
o 0-17
0 0-2
0 0-41
filtrates of these fluids contained barely
detectable levels of free L-arginine. The
arginase estimations were performed after
the ultra-filtration step to avoid problems
with background urea and other chromo-
genic materials.
Since the levels of free L-arginine in
these ascites fluids were well below the
levels necessary to maintain the survival
of mammalian cells in vitro (Eagle, 1959)
and certainly below the levels necessary
for the survival of malignant cells, the
fluids were tested for cytotoxic activity on
L5178Y lymphoma cells and on V79
Chinese hamster lung cells. The fluids were
highly cytotoxic to both cell types and the
cytotoxicity could be abrogated by the
addition of excess free L-arginine (Table
V).
TABLE III.-Arginase levels in C. parvum-induced ascites in CBA female mice
Time after Total
2nd macrophage
C. parvum content x 10-6
Day 1
2
4
6
8
Control mice
5-3
11-7
19-4
22-0
14-1
0 9
Macrophage
arginase
jtmol urea/
min/106 cells
0-20
N.D.
1-18
N.D.
2-12
0
Ascitic fluid
arginase
,tmol urea/
min/ml
0-15
1-0
2-3
2-1
N.D.
Arginine
nmol/ml
22
0
0
Trace
N.D.
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TABLE IV.-Survival of 2-shot C. parvum
mice challenged i.p. with 0 5 X 106
L5178YE cells (groups of 5 mice)
Time after
2nd injection of
C. parvum (days)
0
2
6
8
10
12
Control mice
(no C. parvum)
Mean
survival
(days)
20-0
25-2
31-6
25-6
18-6
17-4
18-0
Furthermore, peritoneal-exudate cells
(85% macrophages) obtained from these
ascites fluids by centrifugation contained
high levels of arginase activity, released
abundant arginase when maintained in
serum-free medium for 24 h, and were
cytotoxic to both V79 and L5178YE cells
in vitro.
Groups of similar mice which had been
given 2 i.p. injections of C. parvum were
challenged by an i.p. injection of 105
L5178Y lymphoma cells on Days 0, 2, 6,
8, 10 and 12 after the second dose. Groups
of control untreated mice were given a
similar dose of lymphoma cells. The sur-
vival of these mice in days is shown in
Table IV, which demonstrates prolonged
survival in the groups challenged on Days
2, 6 and 8 after the second dose of C.
TABLE VI.-Levels of arginase, lysozyme,
arginine and ornithine in normal cisterna
chyli lymph and in lymph draining an
established HSN-TC sarcoma growing in
the mesentery
Lysozyme (,ug/ml)
Arginase ,umol
urea/min/ml
Arginine nmol/ml
Ornithine nmol/ml
Control HSN-TC
9-2 22-0
0 05 0-56
178 54
122 394
parvum. As can be seen from Table III, the
C. parvum-induced ascites on Days 2, 4
and 6 contained abundant arginase
activity and undetectable levels of L-
arginine.
Tumour lymph
The draining lymph from control rats
and from rats bearing HSNTC tumour on
the small intestine after 28 days ofgrowth
was collected for a period of -,1 h (24 h
after insertion of the drainage cannula).
Representative results obtained on such
lymph samples are shown in Table VI.
Lymph draining the tumour contained
elevated levels of lysozyme and arginase.
The arginine content was considerably
lower than the control level and the con-
centration of ornithine increased over
3-fold. These results indicate that the
presence of the tumour (containing large
TABLE V.-Cytotoxic activity ofDay 4 asciticfluid and macrophage supernatantsfollowing
i.p. C. parvum. Materials were tested in medium containing either 20 or 500 ,ug/ml
L-arginine
Material tested
Control medium
(RPMI 1640)
Day 4 Ascites 10%
5%
1%
0.5%
Day 4 Macrophage
supernatant 10%
Normal CBA macrophage
supernatant 10%
Bovine liver arginase
5 u/ml
V79*
, ~-1
20 ,ug/ml 500 jig/ml
Arginine Arginine
1-0 1.0
<0.01 0-12
<0-01 0 43
0.05 0-87
0-11 1.0
0-17 0 93
1-0 1.0
<0-01 0-76
L5178YEt
20 pg/ml 500 pg/ml
Arginine Arginine
+100
-28
-3
+43
+ 72
-17
+98
-36
+100
+27
+88
+100
+100
+87
+100
+63
* Surviving fraction of V79 cells as colonies.
t Growth of L5178YE cells, % control -ve growth reflects lysis of cells.
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niumbers ofmacrophages) had depleted the
downstream lymph of L-arginine. The
elevation of ornithine levels indicates that
this depletion was due to the action of
arginase. The results were identical in
animals whose mesenteric lymph nodes
had previously been excised, indicating
that these nodes play no role in generating
arginase activity.
DISCUSSION
The release of arginase by activated
macrophages in vitro with the consequent
lethal effect on target cells could clearly
be a tissue-culture artefact. Since the
cytotoxic activity of supernatants from
activated macrophages can be abrogated
by the addition of excess L-arginine, a
possible role for such a mechanism oper-
ating in vivo is at first sight improbable.
L-arginine, the final amino acid in the
urea-cycle degradation pathway, is pre-
sent in the extracellular fluid in relatively
high concentrations. An in-vivo role for
arginine deprivation as an effector mech-
anism of macrophages can only be
visualized as a microenvironmental pheno-
menon, occurring at the macrophage sur-
face or within sites of intense macro-
phage infiltration. However, it has been
reported (Senft, 1967) that in mice bearing
extensive schistosome-egg granulomas,
sites of intense macrophage infiltration,
extracellular concentrations of arginine
are severely subnormal throughout the
body, and it has also been noted that
hepatic schistosomiasis in man is asso-
ciated with high levels of circulating
arginase in theplasma (Khalifa et al., 1976).
It is therefore conceivable that extensive
granuloma formation might lead to sys-
temic arginine depletion under conditions
where the liver is unable to respond by
producing more (e.g., in schistosomiasis the
egg granulomas cause substantial liver
damage). However, it is possible that in
both mouse and man damaged hepatic
cells may be responsible for the release of
high levels of arginase.
Arginase is present in high concentra-
tions (i.e., higher than the surrounding
normal tissues) in animnal tumours amul in
granulomas (Edlbacher & Merz, 1927). In
studies of skin carcinogenesis, Roberts &
Frankel (1949) showed that tumours con-
tain more arginase than normal skin.
Bach & Lasnitzki (1949) examined the
arginase content of mouse tumours and
showed that high enzyme activity was
found in slow-growing tumours, whereas
rapidly growing tumours contained low
activity. Thev went so far as to conclude
that arginase "may be part of a defence
mechanism". Since we found that arginase
was readily detectable in macrophages
isolated from growing tumours but not in
the malignant cells, it seems likely that
these earlier workers were examining host-
macrophage infiltration. The observations
of Evans (1973) that tumour-derived
macrophages are cytostatic in vitro could
clearly be attributed to arginase pro-
duction.
The use of Gullino chambers to examine
tissue fluid from within a growing tumour
revealed that there was abundant arginase
activity which was associated with high
levels of lysozyme. Lysozyme, in the
absence of overt granulocyte infiltration
(noted histologically) is a constitutive
marker for cells of the monocyte-macro-
phage series, and we interpret the high
levels of this enzyme in tumour chamber
fluids as reflecting macrophage infiltration.
Serum levels of lysozyme in the tumour-
bearing animals were modestly elevated,
as previously described (Currie & Eccles,
1976). In-vitro examination of tumour
cells and macrophages indicates that the
high levels ofarginase in the tumour extra-
cellular fluids are derived from macro-
phages resident within the tumour. Since
normal rat or mouse peritoneal-exudate
macrophages contained no detectable
arginase activity, we conclude that the
tumour macrophages are metabolically
"activated" (i.e. resemble LPS or zymo-
san-treated cells). Not surprisingly, there
were elevated levels of ornithine and no
detectable free arginine in the tumour
fluids. This complete absence of arginine
from the fluids may not reflect the level of
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arginine within the tumour tissue fluid
since enzymic degradation may have
occurred within the chamber during the
collection period. Since mammalian argi-
nases have a high dissociation content,
the presence of arginase within tumour
extracellular fluid would not rule out the
concomitant presence of low levels of free
L-arginine. Control chambers inserted s.c.
in normal rats provided fluids which con-
tained no detectable arginase activity,
normal levels of lysozyme and normal
levels of L-arginine (similar to serum
levels). Therefore a possible role for the
chambers themselves in inducing host
cellular infiltration in these experiments
can be excluded. However, we had to
discard several previous experiments be-
cause of high levels of lysozyme and
arginase in the fluids from control cham-
bers. These abortive experiments indicate
that in an inflammatory site (induced by
the chamber or by infection) there is
arginase-mediated arginine depletion.
Multiple i.p. injections of C. parvum in
mice induced a macrophage-rich inflam-
matory ascites. The macrophages con-
tained abundant arginase and when cul-
tured in vitro continued to produce and
release the enzyme. The ascitic fluids also
contained high levels of arginase. When
tested against various target cells this
ascitic fluid was highly cytotoxic and its
cytotoxicity could be abrogated by the
addition ofhigh concentrations ofarginine.
After the 2nd i.p. injection of C. parvum
the ascitic fluid arginase levels reached a
peak after 2-6 days, as did the total
numbers of macrophages in the exudate.
Furthermore, when such animals were
challenged with 5 x 105 syngeneic lymph-
oma cells the peak resistance to challenge
coincided with the peak arginase levels.
This ascites model indicates that in sites
of infiltration with activated macrophages
there is likely to be microenvironmental
arginine depletion of the extracellular
fluid, conditions inimical to the successful
implantation andproliferation ofatumour.
Significant levels of arginase activity with
appropriate changes in arginine and orni-
thine levels were also found in the lymph
draining a macrophage-rich tumour, an-
other observation suggesting microen-
vironmental arginine depletion at a site of
macrophage infiltration.
Although macrophages resident within
a growing tumour deplete the extracellular
fluid of arginine, the tumours continue to
grow. Furthermore, in inflammatory
ascites fluid containing no detectable free
L-arginine, resistance to tumour growth is
only partial. The tumours all grew eventu-
ally. To proliferate in vitro the tumour
cells studied all require levels of L-
arginine well above those detected in vivo.
There are several possible explanations for
this paradox. Firstly, it is possible that
the methods used permitted arginine
breakdown during the collection. This is
no doubt true for the Gullino chamber
experiments. Examining the ascites fluids
from C.parvum-treated mice we attempted
to minimize this problem by ultrafiltration
in the cold. However, arginine breakdown
may well have taken place during the
collection and centrifugation. A second
possibility is the rapid in-vivo reutilization
of arginine from dying cells. Although the
tissue fluids may have low arginine con-
centrations, direct cell-to-cell transport
mayprovide sufficient arginine for survival
of some tumour cells.
A possible role for local arginine de-
privation as an effector function of acti-
vated macrophages may not be restricted
to responses to malignant cells. Macro-
phage-mediated suppression of lympho-
cyte proliferation in vitro (Kung et al.,
1977) may be due to arginine breakdown
by macrophage arginase. Its possible role
in vivo is unclear. T cells, for example, on
entry to an inflammatory site may not
need to proliferate. However, animals
whose macrophages are activated by, say,
C. parvum may show depressed T-cell
reactivity due presumably to inhibition of
clonal expansion (Currie, 1976). Arginine
deprivation is known to inhibit the pro-
liferation of polyoma virus in mouse cells
(Winters & Consigli, 1971) and of vaccinia
virus in HeLa cells (Archard & William-
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son, 1971). Furthermore, some parasites
such as schistosomes may rely on the host
as a source ofarginine (Senft, 1967). Local
macrophage infiltration could conceivably
deprive parasites of such arginine sup-
plies.
The administration of arginase for the
treatment of tumours has been reported
to be successful by several authors
(Wiswell, 1951; Bach & Simon-Reuss,
1953). Bach & Swaine (1965) havereported
substantial growth retardation of the
Walker tumour in rats using a highly
purified arginase obtained from horse
liver. The major obstacles to further
exploration of this approach are the
very high Km of mammalian arginases
and their very short half-life when in-
jected. However, the selective cytotoxic
effects of arginine deprivation previously
reported (Currie & Basham, 1978) suggest
that this or similar approaches to therapy
may be worth further exploration.
Dr Cifuentes was supported by the Funda-
cion Cien'tifica de la Associacion Espanola
contra el Caincer.
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